Historical review: Negative efficacy and the constitutive activity of G-protein-coupled receptors
- PMID: 16260046
- DOI: 10.1016/j.tips.2005.10.009
Historical review: Negative efficacy and the constitutive activity of G-protein-coupled receptors
Abstract
The idea that a receptor can produce signalling without agonist intervention and that several antagonists can be 'active' in repressing such spontaneous activity is contained in the concept of ligand-induced conformational changes. Yet, this idea was neglected by pharmacologists for many years. In this article, we review the events that brought inverse agonism and constitutive activity to general attention and made this phenomenon a topic of current research. We also suggest a classification of antagonists based on the cooperativity that links their primary site of interaction with other functional domains of the receptor.
Similar articles
-
Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery.Trends Pharmacol Sci. 2006 Feb;27(2):92-6. doi: 10.1016/j.tips.2005.12.007. Epub 2006 Jan 6. Trends Pharmacol Sci. 2006. PMID: 16406086 Review.
-
Inverse agonists: tools to reveal ligand-specific conformations of G protein-coupled receptors.Sci STKE. 2004 Jan 5;2004(215):pe1. doi: 10.1126/stke.2152004pe1. Sci STKE. 2004. PMID: 14722344 Review.
-
Inverse agonism or neutral antagonism at G-protein coupled receptors: a medicinal chemistry challenge worth pursuing?Eur J Pharmacol. 2006 Dec 28;553(1-3):1-9. doi: 10.1016/j.ejphar.2006.09.032. Epub 2006 Sep 26. Eur J Pharmacol. 2006. PMID: 17081515 Review.
-
The evasive nature of drug efficacy: implications for drug discovery.Trends Pharmacol Sci. 2007 Aug;28(8):423-30. doi: 10.1016/j.tips.2007.06.005. Epub 2007 Jul 19. Trends Pharmacol Sci. 2007. PMID: 17659355 Review.
-
Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.J Mol Biol. 2008 Oct 3;382(2):539-55. doi: 10.1016/j.jmb.2008.06.084. Epub 2008 Jul 7. J Mol Biol. 2008. PMID: 18638482
Cited by
-
G-protein-coupled receptor heteromers: function and ligand pharmacology.Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S90-8. doi: 10.1038/sj.bjp.0707571. Epub 2007 Nov 26. Br J Pharmacol. 2008. PMID: 18037920 Free PMC article. Review.
-
mGlu4R, mGlu7R, and mGlu8R allosteric modulation for treating acute and chronic neurodegenerative disorders.Pharmacol Rep. 2024 Dec;76(6):1219-1241. doi: 10.1007/s43440-024-00657-7. Epub 2024 Sep 30. Pharmacol Rep. 2024. PMID: 39348087 Free PMC article. Review.
-
Effects of N-Substituents on the Functional Activities of Naltrindole Derivatives for the δ Opioid Receptor: Synthesis and Evaluation of Sulfonamide Derivatives.Molecules. 2020 Aug 20;25(17):3792. doi: 10.3390/molecules25173792. Molecules. 2020. PMID: 32825410 Free PMC article.
-
Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma.Naunyn Schmiedebergs Arch Pharmacol. 2008 Aug;378(2):149-69. doi: 10.1007/s00210-008-0263-1. Epub 2008 Feb 16. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18278482 Review.
-
Full and partial agonists of thromboxane prostanoid receptor unveil fine tuning of receptor superactive conformation and G protein activation.PLoS One. 2013;8(3):e60475. doi: 10.1371/journal.pone.0060475. Epub 2013 Mar 28. PLoS One. 2013. PMID: 23555978 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources